MSCs (IsletOne Therapeutics)

N/A

Report date: 2025/01/26 17:12:24

Base Information

Drug NameMSCs (IsletOne Therapeutics)
Drug Alias NameIO-4
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIsletone
China Registration ClassN/A

Develop Information

Active CompaniesIsletone
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A